VERMOX 100 Milligram Tablets

Country: Ireland

Language: English

Source: HPRA (Health Products Regulatory Authority)

Active ingredient:

MEBENDAZOLE

Available from:

McNeil Healthcare (Ireland) Ltd

ATC code:

P02CA01

INN (International Name):

MEBENDAZOLE

Dosage:

100 Milligram

Pharmaceutical form:

Tablets

Prescription type:

Product not subject to medical prescription

Therapeutic area:

Benzimidazole derivatives

Authorization status:

Authorised

Authorization date:

2009-07-17

Patient Information leaflet

■

This medicine is used to treat threadworm and other common worm
infections of the gut.
■

This medicine is for use by adults and children aged over 2 years.
■

DO NOT USE THIS MEDICINE:
■

There are some people who should not use this medicine. _To fi nd
out if you are one of them _
_see section 2 _
▶
■

If you have ever had a BAD REACTION to any of the ingredients. _To
view the list of ingredients _
_see section 6 _
▶
■

SPEAK TO YOUR DOCTOR:
■

If you are taking any other medicines. _See section 2_ 
▶
■

FOLLOW THE DOSAGE INSTRUCTIONS CAREFULLY. These are shown in the
dosage table. _See section 3_ 
▶
NOW READ THIS WHOLE LEAFL ET CAREFULLY BEFORE YOU USE THIS
MEDICINE. Keep the leafl et: you might 
need it again.
1
 WHAT THE MEDICINE IS FOR
Vermox Tablets is a medicine which is used to treat threadworms
(sometimes known as pinworms) 
and other common worm infections eg (whipworm, roundworm, hookworm).
The tablets contain 
mebendazole, which is one of a group of medicines called
‘anthelmintics’. 
This medicine is for use in adults and children aged over 2 years.
2
 BEFORE TAKING THIS MEDICINE
This medicine is suitable for most adults and children, but a few
people should not use it. If you 
are in any doubt, talk to your doctor or pharmacist. 
 DO NOT USE THIS MEDICINE…
■

If you are HYPERSENSITIVE (allergic) to any of the ingredients.
■

If it is for a CHILD UNDER 2 YEARS.
■

If you are PREGNANT OR THINK YOU ARE PREGNANT.
■

If you are BREAST-FEEDING.
If any of these apply to you, GET ADVICE FROM A DOCTOR OR PHARMACIST
BEFORE USING VERMOX TABLETS.
TALK TO YOUR DOCTOR OR PHARMACIST...
■

If you are taking any OTHER MEDICINES, INCLUDING: 
■

_Metronidazole_ (a drug used to treat BACTERIAL AND PROTOZOAN
INFECTIONS) as a serious skin 
reaction can rarely occur.
■

_Cimetidine_ (a medicine used to treat excess STOMACH ACIDITY).
OTHER WORM INFECTIONS _(TAENIASIS AND STRONGYLOI

Summary of Product characteristics

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Vermox 100mg Tablets.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 100 mg mebendazole.
Excipients: Each tablet also contains 0.06 mg Sunset Yellow (E110).
For a full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Tablet.
Faintly orange circular, flat, half –scored, bevel-edged tablet with ‘ME 100’ inscribed on one side and ‘Janssen’ on the
other.
The half-score is only to facilitate breaking for ease of swallowing and not to divide into equal halves.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
As an anthelmintic against gastrointestinal infestations caused by nematodes and cestodes, including enterobiasis,
ascariasis, trichuriasis, ankylostomiasis, strongyloidiasis and taeniasis.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Method of administration:
Oral Use.
Adults and children 2 years or older:
Tablets may be chewed or swallowed whole. Crush the tablet before giving it to a young child. Always supervise a
child while they are taking this medicine.
4.3 CONTRAINDICATIONS
Use in pregnancy or lactation in women breast feeding infants. It is not known if mebendazole crosses the placenta
or is excreted in breast milk.
Ascariasis, trichuriasis,
ankylostomiasis and mixed infections:
100 mg twice daily for three
consecutive days.
Enterobiasis:
100 mg as a single dose repeated after
2 to 4 weeks.
Taeniasis and
strongyloidiasis:
_Adults: _200 mg twice daily for three
consecutive days.
_Children 2 years or older: _100 mg
twice daily for three consecutive days.
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 05/12/2016_
_CRN 2185339_
_page number: 1_
In persons with a known hypersensitivity to